Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The scientific study is intended to show that external non-invasive electromagnetic stimulation can be used to safely and effectively stimulate the phrenic nerve in awake healthy subjects as well as in ventilated, anesthetized patients and that the stimulation can generate a diaphragmatic contraction that generates significant breath volume - a Controlled Own Breath (COB).
Also of interest is the reproducibility of the generated diaphragmatic movements and the reliability of different feedback signals for detecting the generated diaphragmatic contraction. This applies to inspiration and expiration detection for subsequent synchronization mechanisms of the magnetic stimulator for patient-initiated breathing as well as to contraction intensity. Further, the characterization of the position finding process is of great importance, so that technical developments can further simplify the process of coil positioning in the future. The possible occurrence of discomfort and pain sensation will also be investigated in awake healthy volunteers. Different stimulation protocols will be used.
Finally, it will be investigated whether an adjusted coil position still triggers reproducible diaphragmatic contractions after removal and repositioning in the same configuration. The knowledge gained will be used to further develop the technique and to prepare a study in critically ill, ventilated patients where the diaphragmatic muscle is to be treated preventively by stimulating the phrenic nerve, in order to prevent atrophy of the muscle.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Phrenic nerve stimulation with Stimit Activator | Experimental |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Stimit Activator | Device | The Stimit Activator Device is composed of three components.
|
| Measure | Description | Time Frame |
|---|---|---|
| Change in airway pressure / endpoint Group 1: | The primary outcome / endpoint is the change in airway pressure at the mouth during stimulation as seen with or without the use of the ventilator | During stimulation |
| Discomfort / pain during stimulation measured by Visual Analogue Scale / endpoint Group 1: | The primary outcome / endpoint is the level of discomfort / pain during stimulation, measured by Visual Analogue Scale(0-100, with 100 being worst pain / discomfort) | During stimulation |
| Change in airway pressure / endpoint Group 2: | The primary outcome / endpoint is the change in airway pressure during stimulation as seen with or without the use of the ventilator during stimulation. | During stimulation |
| Measure | Description | Time Frame |
|---|---|---|
| Diaphragmatic contraction | Diaphragmatic contraction at 20 percent / 30 percent / 40 percent stimulation intensity at the optimal stimulation site, at 25 Hz and 2s stimulation time | During stimulation |
| Feedback signals |
Not provided
Inclusion Criteria:
Exclusion Criteria:
chronic lung diseases (bronchial asthma, COPD)
known diaphragmatic weakness
known neurological conditions with motor muscle weakness
known paralysis of the phrenic nerve
conditions that limit the mobility of the diaphragm (high intra-abdominal pressure, ascites, BMI >30)
not able to read and understand the national language German
skin lesions, infections or strictures in the neck area
persons with Implanted cardiac support systems (pacemaker, implanted defibrillator)
persons with implanted medical pumps
pregnant women
persons deprived of liberty by administrative or judicial decision or under legal guardianship.
Participation in another clinical trial
Applicable for group 2 (intubated and mechanically ventilated) patients: Exclusion criteria at the time of stimulation:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Michael Baumberger, MD | Swiss Paraplegic Center Nottwil | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Swiss Paraplegic centre | Nottwil | Switzerland |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Open-label, sponsor-initiated feasibility study. 2 groups of patients treated - healthy subjects and elective surgery patient
Not provided
Not provided
Not provided
Not provided
|
Change of the maximum value of the feedback signals in percent of the maximum depending on the coil position (in 0.5 cm steps; at least 3 steps in each direction)
| During stimulation |
| Time stimulation start to end | Time (mean value & standard deviation) between stimulation start and stimulation end (trigger signal start and end) until the feedback signals from:
| During stimulation |
| Correlation stimulation intensity and diaphragm contraction | Correlation between stimulation intensity (power output in percent) and diaphragm contraction, measured by tidal volume, at the optimal coil position at given frequency (25 Hz) and given stimulation duration | During stimulation |
| Optimal stimulation site - distance | Distance from anatomical landmark (a) to optimal stimulation site (b) and phrenic nerve (c) using ultrasound and between b and c | During stimulation |
| Optimal stimulation site - time | Time from the start of coil positioning to finding a coil positioning which produces the maximum diaphragmatic contraction at a given stimulation intensity and frequency of 25 Hz | During stimulation |
| Tidal volumes | The mean and standard deviation of generated tidal volumes for ten stimulations performed without the subject being ventilated | During stimulation |
| Skin reactions / musle activation | For Group 1: evaluation of stimulation-induced local skin reactions or muscle activation leading to paresthesia in the dental area | During stimulation |
| Safety outcome | The safety outcome/ endpoint is the occurrence of the following events during stimulation:
| During stimulation and postoperatively, usually within 2-3 hours |